Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal...

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Antimicrobial efficacy is linked to bacterial replication rates.
• Modulating bacterial replication can potentially alter antimicrobial agent effectiveness.

Purpose of the Study:

• To investigate if a growth-promoting agent can enhance the bactericidal effects of an antimicrobial agent.
• To evaluate the combination of levofloxacin and norepinephrine against *Escherichia coli* in an *in vitro* infection model.

Main Methods:

• A 24-hour one-compartment *in vitro* infection model simulating human levofloxacin pharmacokinetics.
• Exposure of *Escherichia coli* JMI 21711R to levofloxacin monotherapy versus levofloxacin with continuous norepinephrine infusion.
• Bacterial density and drug concentrations were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Main Results:

• Norepinephrine and no-treatment controls showed immediate failure.
• Levofloxacin monotherapy showed slow bacterial density reduction over time.
• The levofloxacin-norepinephrine combination achieved a 2-log10 CFU reduction in 6-8 hours but led to rapid regrowth of a highly resistant subpopulation (MIC 64 mg/liter).

Conclusions:

• Increasing bacterial replication rate with a pharmaceutical agent can enhance the rate and magnitude of antimicrobial bactericidal effect.
• This combination strategy also rapidly selects for antimicrobial resistance.
• Further research is needed to balance enhanced killing with resistance development.